NCT05043168

Kidney Histopathology After COVID-19 and SARS-CoV-2 Vaccination

Kidney Histopathological Features in Patients After COVID-19 and SARS-CoV-2 Vaccination

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 42 (actual)
• Sponsor: University of Giessen · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: —

Summary

The study aims to summarize kidney histopathological findings in patients with coronavirus disease 2019 (COVID-19) and post-severe acute respiratory syndrome-coronavirus-type 2 (SARS-CoV-2) vaccination.

Detailed description

The SARS-CoV-2 pandemic has had substantial global morbidity and mortality. While COVID-19 is most commonly characterized as a respiratory illness, extrapulmonary manifestations are a prominent part its clinical spectrum. Kidney disease is a common finding in COVID-19, and has also been rarely described after SARS-CoV-2 vaccination. The main objective of this study is to summarize kidney histopathological findings in patients with COVID-19 and post-SARS-COV-2 vaccination, in whom native kidney biopsy was performed and samples were obtained by the Nephropathology Section, Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Conditions

• Covid19
• Vaccination Reaction

Timeline

• Start date: 2021-09-18
• Primary completion: 2021-12-31
• Completion: 2022-05-17
• First posted: 2021-09-14
• Last updated: 2022-05-19

Locations

1 site across 1 country: Germany